Saturday, November 23, 2024
Facebook Linkedin Twitter
HomeTagsBrain health diagnostics

brain health diagnostics

Biotechnology

C2N Diagnostics Releases the PrecivityAD2™ Blood Test for Clinical Care, a Robust Assay with High Concordance to Amyloid PET and CSF

News Desk -
C2N Diagnostics, a leader in advanced brain health diagnostics, announced the release of the PrecivityAD2 blood test, a clinical care assay that meets the...
Healthcare

C2N Diagnostics’ Precivity-Related Blood Biomarkers Shown to Improve Diagnostic Accuracy and Future Risk Prediction of Alzheimer’s Disease in Two Studies Presented at AD/PD 2023

Business Wire -
C2N Diagnostics, a leader in advanced brain health diagnostics, announced the presentation of two research studies at the AD/PD 2023 International Conference on Alzheimer’s...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us